Toxicological and metabolic considerations for histone deacetylase inhibitors.
about
Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune TherapySmall molecule inhibitors of zinc-dependent histone deacetylasesHistone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammationEpigenetic regulation of microRNAs controlling CLDN14 expression as a mechanism for renal calcium handlingAntidepressant action of HDAC inhibition in the prefrontal cortex.Non-sirtuin histone deacetylases in the control of cardiac agingEpigenetic mechanisms in cerebral ischemia.Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation.Epigenetic approaches for bipolar disorder drug discovery.Entinostat (SNDX-275) for the treatment of non-small cell lung cancer.Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.Targeted Cancer Therapies and QT Interval Prolongation: Unveiling the Mechanisms Underlying Arrhythmic Complications and the Need for Risk Stratification Strategies.Megakaryocyte lineage development is controlled by modulation of protein acetylation.
P2860
Q26783032-0B701A85-BBE0-49B5-8764-68584FDD9353Q26824515-6F2FEE8F-D145-4FDC-B6B5-2A06072976C3Q28076052-FDAA7E23-E4A2-4588-97E7-E8F5FB8C048FQ35124237-A35DDA67-E9C8-46CD-ADC7-192D8C6C08A0Q35638873-D090CAD5-0651-4557-8138-342EE762E4D8Q35695849-6FA0AEC2-0B62-4EBE-B6AF-72898EC02B78Q37150340-B5B91963-0B78-49AC-B6AE-548118F1CC4FQ37706926-CEACD9DD-AA4F-44BF-A759-083951F0ECC8Q38215889-B3A5B206-DE2F-446D-8596-1E399A516871Q38534163-8D76AC03-D2BA-4B1E-9287-265C830F8334Q38792714-3317C142-EF6C-467A-8AE3-60B262CB2F38Q38956949-B72A04F4-0F5E-4ED2-B26E-EA923D029735Q52716487-832B9CAF-22CA-4D11-8A5E-D5753341CFF8
P2860
Toxicological and metabolic considerations for histone deacetylase inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Toxicological and metabolic considerations for histone deacetylase inhibitors.
@en
type
label
Toxicological and metabolic considerations for histone deacetylase inhibitors.
@en
prefLabel
Toxicological and metabolic considerations for histone deacetylase inhibitors.
@en
P2093
P2860
P1476
Toxicological and metabolic considerations for histone deacetylase inhibitors.
@en
P2093
Joanna Fraczek
Tamara Vanhaecke
Vera Rogiers
P2860
P304
P356
10.1517/17425255.2013.754011
P407
P577
2013-01-04T00:00:00Z